Bushra A. Kanaan

Dr. Bushra A. Kanaan

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Mushtak T.S. Al-OuqailiMushtak T.S. Al-Ouqaili
Mushtak T.S. Al-Ouqaili
Rawaa A. HusseinRawaa A. Hussein
Rawaa A. Hussein
BKBushra A. Kanaan
Bushra A. Kanaan
AAAhmed T. S. Al-Neda
Ahmed T. S. Al-Neda
Burkholderia cepacia and Aeromonas sobria are difficult to eradicate due to their innate resistance to a variety of medications, and cause various diseases. The aim of this study was to investigate the occurrence of carbapenemase genes and patterns of antibiotic resistance in isolates of B. cepacia and A. sobria. Randomly, 120 clinical specimens have been collected in patients with nosocomial infections. Selective media were used to culture ear swabs, urine, burns, wounds and cerebrospinal fluids. According to biochemical tests and the VITEK-2 system, 75 of these demonstrated positive growth with B. cepacia and A. sobria. Metallo-β-lactamase (MBL) synthesis was phenotypically screened using the meropenem-EDTA disc test. The recA gene in B. cepacia and the genes encoding carbapenemase in both species were found using PCR tests. Among the 75 isolates assessed 20 (26.6%) were A. sobria and 55 (73.3%) were B. cepacia. Piperacillin, cefepime, and ceftriaxone showed antimicrobial resistance of 100%, followed by ceftazidime (97.3%), cefazolin (96%), and piperacillin/ tazobactam (94.6%). Intermediate resistance was reported with aztreonam (61.3%), meropenem (49.3%), trimethoprim-sulfamethoxazole (49.3%), gentamicin (46.6%), levofloxacin (44%), and ciprofloxacin (44%). It is important to note minocycline (40%), amikacin (40%) imipenem (36%) and tigecycline (34.6%), had the lowest resistance rates, hence their relatively higher efficacy against the tested isolates. In this investigation, the B. cepacia was confirmed to be found via the recA gene. The overall prevalence of carbapenemase genes was 92.8% (52/56) with blaKPC accounting for 80.8% (42/52) and blaGES for 19.2% (10/52) of the total. Specifically, 38 (90.51%) of the 42 (76.36%) B. cepacia isolates that were positive in carbapenem resistance carried blaKPC gene, 2 (4.81%) isolates carried blaGES, and 2 (4.81%) had no detectable carbapenemase gene. In the case of the 14 A. sobria carbapenem-resistant isolates, there were 4 isolates (28.6%) that had blaKPC, 8 isolates (57.1%) that had blaGES and there were 2 isolates (14.3%) that did not have any carbapenemase genes. None of isolates studied tested positive for the blaIMP gene. The recent study concluded that recA gene identification was more sensitive and specific technique for detection B. cepacia complex isolates. Since the prevalence of carbapenemase producers is high, careful infection control measures, rapid diagnostics, and antimicrobial stewardship must be implemented by clinicians. It is necessary that combination therapy be guided and early detectable to ensure better outcomes and restrict resistance.

9 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
BKBushra A. Kanaan
Bushra A. Kanaan
Mushtak T.S. Al-OuqailiMushtak T.S. Al-Ouqaili
Mushtak T.S. Al-Ouqaili
YMYasin H. Majeed
Yasin H. Majeed
WTWoei-Yenn Tong
Woei-Yenn Tong
Helicobacter (H.) pylori is a Class 1 carcinogen affecting half the global population. In the recent years, spiking emergence of antibiotic-resistant bacterial populations around the world has made treatment of infectious diseases arduous. With the improved understanding of bacteriophage biology, and the availability of its complete genome sequences led to a resurgence of interest in phage therapy as an antimicrobial strategy. The cross-sectional study was enrolled 100 adult patients undergoing elective upper GI endoscopy at Ramadi Teaching Hospital, Iraq. H. pylori was cultured from gastric biopsies under microaerophilic conditions and confirmed by biochemical testing and quantitative real-time PCR (qRT-PCR). Bacteriophages were enriched from filtered gastric juice against a mixed host pool, isolated by spot test and double-layer agar plaque assay, purified to high-titer stocks, and characterized by electron microscopy, host range, efficiency of plating, and chloroform sensitivity. Genomes were sequenced (Illumina iSeq 100), assembled and annotated bioinformatically. H. pylori was isolated from 31/100 patients. Two lytic phages (MBP1, MBP2) were isolated from gastric juice, lysing 83.9% and 77.4% of clinical isolates, respectively, with their cocktail lysing 100%. Both phages were chloroform-sensitive with distinct morphologies by TEM. Their circular genomes (40,704 and 40,666 bp) contained no virulence or resistance genes. VIRIDIC analysis classified MBP1 within an existing genus and MBP2 as a novel genus (GenBank PZ883692, PZ564648). The first isolation and genomic characterization of H. pylori-specific bacteriophages from gastric juice in Iraq. The two phages demonstrated broad, synergistic lytic activity against all clinical isolates, favourable safety profiles free of virulence and resistance genes, and taxonomic novelty, including one representing a potentially novel genus. These findings support gastric bacteriophages as promising, safe candidates for phage-based therapies against H. pylori infection.

29 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
Mushtak T.S. Al-OuqailiMushtak T.S. Al-Ouqaili
Mushtak T.S. Al-Ouqaili
Rawaa A. HusseinRawaa A. Hussein
Rawaa A. Hussein
BKBushra A. Kanaan
Bushra A. Kanaan
AAAhmed T.S. Al-Neda
Ahmed T.S. Al-Neda
Burkholderia cepacia and Aeromonas sobria are difficult to eradicate due to their innate resistance to a variety of medications, and cause various diseases. The aim of this study was to investigate the occurrence of carbapenemase genes and patterns of antibiotic resistance in isolates of B. cepacia and A. sobria. A cross-sectional study was conducted in the Ramadi Teaching Hospitals in the Al-Anbar Governorate in 2024. Various study samples, were used to collect the studied bacteria. The antibiotic resistance was detected by the VITEK®2 System. The presence of carbapenemase genes was confirmed via PCR technique. In this investigation, seventy-five (75) isolates of A. sobria and B. cepacia were assessed. Of these, A. sobria made up 16.6% (n = 20) while B. cepacia accounted for 45.8% (n = 55). The study isolates showed highest antimicrobial resistance to piperacillin, cefepime, ceftriaxone (100%), ceftazidime (97.3%), and lowest antimicrobial resistance to imipenem (36%). The result showed 55/57 recA gene positive for differentiated B. cepacia complex from other Burkholderia spp. The overall prevalence of carbapenemase genes was 92.8%% (52/56) with bla KPC accounting for 80.8% (42/52) and bla GES for 19.2% (10/52) of the total. The 42 B. cepacia isolates that tested positive for carbapenem resistance were constituted of 38 bla KPC (n = 38) and two bla GES (n = 2); in contrast, four bla KPC (n = 4) and eight bla GES (n = 8) were present in the A. sobria isolates that tested positive for carbapenems resistance. None of isolates studied tested positive for the bla IMP gene. The recent study concluded that recA gene identification was more sensitive and specific technique for detection B. cepacia complex isolates. There was a notable predominance of bla KPC and bla GES carbapenemase producers among the isolates under investigation. The bla IMP gene was not found in any of the research isolates.